BIVDA Press Releases

Mar 23, 2021
BIVDA welcomes new Government research strategy BIVDA, the trade association for British in-vitro diagnostic companies, has welcomed the publication of the Government’s new research strategy ‘Saving and improving lives: the future of UK clinical research delivery’. The strategy sets out plans to strengthen the UK’s renowned expertise as a world-leader in designing and delivering medical and scientific research. It is built around 5 key themes:  Clinical research...
Read More
Mar 22, 2021
BIVDA Welcomes new EUCOPE – Charles River Associates report on advanced diagnostics  BIVDA, the UK trade association for in-vitro diagnostic companies, has welcomed the publication of a White Paper on Advanced Diagnostics by EUCOPE and Charles River Associates that puts forward concrete proposals to support understanding of the advanced diagnostics sector, the benefits it brings and related requirements for success . The health benefits of genomics and advanced genomic testing ar...
Read More
Mar 18, 2021
MICROSENSDX RapiPRO™ LAMP for SARS-CoV-2 RECEIVES CE MARK APPROVAL Pioneering British biotech MicrosensDx has announced that its RapiPRO™ LAMP SARS-CoV-2 test has received CE Certification.The business, an established molecular diagnostics innovator with a 20-year history in IVD development, is a recognised expert in Loop-mediated Isothermal Amplification (LAMP) testing, having developed proprietary tuberculosis (TB) diagnostics using the technology.MicrosensDx has revealed robu...
Read More
Mar 17, 2021
PulmoBioMed – a new medtech spin-out in the North East of England Launched with funding from Northumbria University and Innovate UK, and with its first product PBM-HaleTM in clinical trials in Europe, PulmoBioMed now seeks to close its £2.5 m initial equity capital raise. PBM-HaleTM, a Class 1 medical device, is designed to collect exhaled breath condensate samples in a non-invasive manner. The hand-held device captures a wide range of biomarkers including protein, RNA, DNA...
Read More
Mar 04, 2021
Microsemi CRP LC-767G HORIBA Medical, specialists in automated in vitro diagnostic systems for haematology, haemostasis and clinical chemistry analysis, has obtained the CE Mark certification for its new generation of the Microsemi CRP haematology analyser, the Microsemi CRP LC-767G. This new generation analyser Microsemi CRP LC-767G is more compact and proposes enhanced software and network connectivity providing higher memory, usability plus a new parameter: Granulocytes-to- Lymphocy...
Read More
Mar 03, 2021
Press Release - BIVDA Comments on Budget 2021 support for life sciences  BIVDA, the trade association for British in-vitro diagnostic companies, has commented on today’s Budget announcements, outlined in the House of Commons by Chancellor Rishi Sunak.  The British IVD industry is a growing and innovative part of our economy. This Budget, coming as the health service and our economy begin to recover from the effects of the COVID-19 pandemic, offers an opportunity to ensure the IVD...
Read More
Mar 03, 2021
New England Biolabs® Introduces ARTIC Products for SARS-CoV-2 Sequencing New kits improve upon well-established ARTIC protocols for SARS-CoV-2 genome sequencing with optimized reagents and improved uniformity of coverage depth for Illumina® and Oxford Nanopore Technologies® next generation sequencing (NGS) platforms IPSWICH, Mass, February 25, 2021 — New England Biolabs (NEB®) today released three kits based on the ARTIC Network protocols ...
Read More
Mar 02, 2021
BIVDA calls for a diagnostics industry of ‘critical mass’ to help fight future health challenges  BIVDA, the trade association for British in-vitro diagnostic companies, has submitted a response to the Government’s new Innovation Taskforce, set up by the Prime Minister to identify and develop proposals across a range of areas that will drive innovation and competitiveness, reduce barriers to start-ups and scale-ups, create opportunities for innovation to make the most of c...
Read More
Feb 24, 2021
NHSEI SBRI Healthcare grant for Psyros’ rapid, ultra-sensitive test for heart attack marker Firm raising £2.5m seed round to support further development of prototypeDiscovery Park, Sandwich, UK, February 24 2021 – Psyros Diagnostics, which is developing ultra-sensitive, ultra-fast, point of care diagnostics based on single molecule counting, has been awarded a £99,400 grant by NHSEI SBRI Healthcare1 to advance their novel test for the heart attack marker troponin. Ps...
Read More
Feb 23, 2021
RANDOX PROCESSES ITS 10 MILLIONTH COVID-19 TEST AND DETAILS INVESTMENT IN TESTING CAPACITY Randox Laboratories has confirmed that it has processed its 10 millionth sample for the UK’s COVID-19 National Testing Programme, making it the first Pillar 2 testing laboratory to achieve this milestone.  This achievement is based upon a £85 million investment since March 2020 in facilities and equipment at Randox’s laboratories in Northern Ireland.  As a key partner labor...
Read More
Page 3 of 12 [3]